Title: Liang Y, et al. Effect of canagliflozin on renal threshold for glucose, glycemia, and body weight in normal and diabetic animal models. PLoS One. 2012;7(2):e30555.
1030825-21-8
1222075-02-6
1358581-37-9
2146135-87-5
842133-16-8
866607-35-4
929095-22-7 | GSK461364analogueII | AA01EQC5 | MFCD18089837
1139719-95-1 | 1-Benzyl-7-methylquinolin-1-ium bromide | AA01EQOX | MFCD05149344
1280655-24-4 | (S)-2-Methyl-N-[(2S)-1,1,1-trifluoro-4-oxo-4-phenylbutan-2-yl]propane-2-sulfinamide | AA01ERK0 | MFCD28369630
146041-88-5 | 1-(1-Methyl-1,2,3,4-tetrahydroquinolin-4-yl)pyrrolidin-2-one | AA01EU4D | MFCD00963265
1823644-43-4 | 1-(2,2,2-Trifluoroethyl)-3-(trifluoromethoxy)-benzene | AA01EUCH | MFCD28166239
2443-77-8 | 2,2'-(Sulfonylbis(methylene))bis((trifluoromethyl)benzene) | AA01EUIQ | MFCD28048674
302938-07-4 | 3-Ethyl-5-[[3-(4-fluorophenyl)-1-phenyl-1H-pyrazol-4-yl]methylene]-2-thioxo-4-thiazolidinone | AA01EUPD | MFCD01947744
33951-30-3 | 3,4-Dimethoxyphenylmethylsulfone | AA01EVII | MFCD03789187
405910-36-3 | 2,6-Dimethyl-4-(2-nitro-4-(trifluoromethyl)phenyl)morpholine | AA01EVRN | MFCD02018696
51843-14-2 | 1,2-Dimethylisoquinolin-2-ium iodide | AA01EW8R | MFCD00540399